Top Markets
#1 Verus Coin Verus Coin +45.29%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.62%
#3 Status Status +18.18%
#4 GoPlus Security GoPlus Security +16.88%
#5 Wrapped NXM Wrapped NXM +14.96%
#6 Ontology Gas Ontology Gas +12.84%
#7 Bedrock Bedrock +12.01%
#8 Pons Pons +8.83%
#9 DMT-NAT DMT-NAT +8.72%
#10 BankrCoin BankrCoin +7.39%
Coin of the day
Verus Coin Verus Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Rang in Aktien #33958
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Aktienkurs
$1.83
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$6.53M
Veränderung (1 Tag)
-1.61%
Veränderung (1 Jahr)
-85.57%
Land
US
Handel Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Kategorie

Healthcare
Preis CVKD mit Marktkapitalisierung von B
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
CVKD
$1.83
Marktkapitalisierung von Cadrenal Therapeutics, Inc. Common Stock(CVKD)
Marktkapitalisierung: $6.53M
Mit Stand August 2026 hat Cadrenal Therapeutics, Inc. Common Stock eine Marktkapitalisierung von $6.53M. Das macht Cadrenal Therapeutics, Inc. Common Stock laut unseren Daten zum 33958th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Cadrenal Therapeutics, Inc. Common Stock von 2023 bis 2026
CVKD im Vergleich zu den Top 5 der beliebtesten stocks
Preis für CVKD Vermögenswert B Marktkapitalisierung von B Ergebnisse
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,528,108 $6.53M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +83,503,043.85%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,258,511 $6.53M
Apple Inc. Apple Inc.
AAPL
$4.490T +68,770,974.14%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,166,684 $6.53M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +63,753,110.65%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$1,030,444 $6.53M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +56,308,337.14%
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock
$794,075 $6.53M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +43,391,995.61%